Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumateperone in Pediatric Bipolar Depression
NCT06372964Phase 3Recruiting
- Sponsor
- Intra-Cellular Therapies
- Start
- May 2024
- Primary completion
- Oct 2031
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of lumateperone in bipolar disorder (BD), sponsored by Intra-Cellular Therapies. Started May 2024; status: recruiting.
02
Drugs
lumateperone
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT06372964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06372964.